Lynch syndrome

Diagnosis and Testing

What is the difference between tumor testing and germline testing?

There are key differences between analyzing the DNA from a tumor and analyzing DNA from your blood. It is not uncommon now to have DNA analysis (DNA sequencing) performed on a tumor sample. Outcomes can sometimes affect treatment options. Most of the genetic changes found in a tumor sample are new (somatic) changes. Somatic mutations are not present at birth, but rather they arise randomly later in life. Many somatic changes are made during the growth of a tumor. MLH1, MSH2, MSH6, PMS2, or EPCAM gene mutations found in a tumor does not confirm that a person has Lynch syndrome.

Lynch syndrome is caused by germline mutations. These are genetic changes that we have in our DNA from birth, and we expect to find them in every cell in our body. DNA sequencing on blood or saliva samples can detect these germline mutations.

SOURCE: Emory University - Department of Human Genetics in collaboration with ThinkGenetic • https://www.thinkgenetic.com/diseases/lynch-syndrome-i/diagnosis-testing/2255 • DATE UPDATED: 2016-05-27

References

http://www.cancer.gov/about-cancer/causes-prevention/genetics/overview-pdq#link/_2616_toc

This content comes from a hidden element on this page.

The inline option preserves bound JavaScript events and changes, and it puts the content back where it came from when it is closed.

Remember Me